drugset / Trial / NCT00931996

Oculomotor and Spatial Cognition Deficits in Schizophrenia

NCT00931996

NaSingle-groupOpen-labelBasic science

Summary

DESCRIPTION: (Verbatim from the Applicant's Abstract) Abnormalities of eye movement control and spatial cognition are well-established deficits in schizophrenia. However, the regional disturbances in brain function causing these deficits are not yet known. This application proposes a series of integrated behavioral studies designed to identify causes of deficits in schizophrenia.

Timeline

Start
2009-06
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified

Indications